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Abstract
A serological survey was performed to determine the prevalence of antibodies against human bocavirus in an Apulian population. Anti-
hBoV IgG antibodies were analysed in 1206 inhabitants (age range, 1 month–84 years) using a standardized ELISA test based on the use
of recombinant hBoV VP2 virus-like particles. In total, 1075 (89.1%) of 1206 participants (mean age 32 ± 24.8 years) displayed anti-
hBoV-IgG. The seroprevalence increased significantly (p < 0.0001) in children from 2–4 years (64.2%) to 5–9 years (96.4%). A similar
trend was observed in both male and female subjects. In conclusion, our results show that hBoV infection is common in this population,
especially in children.
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Abstract
Enterovirus-positive samples diagnosed in Marseille (January 2009 to September 2011) were screened for EV71 by real-time RT-PCR.
EV71 was detected in three children below the age of 2 years with no history of overseas travel; two of these cases were associated
with severe clinical presentation. Viruses demonstrated genetic similarity to other European genogroup C2 strains. Strain MRS/09/3663
complete sequencing revealed 97.6% identity across the entire genome with a 2008 Singapore isolate, without signs of possible recombi-
nation events. To our knowledge, this is the first detection of EV71 infection in Marseille, France, that confirms the current circulation
of EV71 in France.
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Abstract
Rapid documentation of respiratory specimens can have an impact on the management of patients and their relatives in terms of pre-
ventive and curative measures. We compared the results of the Xpert Flu assay (Cepheid) with three real-time RT-PCR assays using
127 nasopharyngeal samples, of which 75 were positive for influenza A (with 52 identified as A/H1N1-2009) and 52 were positive for
influenza B. The Xpert Flu assay presented a quasi-absence of non-interpretable tests, and showed sensitivity and specificity of 100%
and 100% for Flu A, 98.4% and 100% for A/H1N1-2009, and 80.7% and 100% for Flu B.
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